Neuroprotective Effect of Statins in a Rat Model of Chronic Ocular Hypertension
Glaucoma is an optic neuropathy in which the degeneration of retinal ganglion cells (RGCs) results in irreversible vison loss. Therefore, neuroprotection of RGCs from glaucomatous afflictions is crucial for glaucoma treatment. In this study, we aimed to investigate the beneficial effects of statins...
Guardado en:
Autores principales: | , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/c4801c941ff54baea351cff86f4deb7e |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:c4801c941ff54baea351cff86f4deb7e |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:c4801c941ff54baea351cff86f4deb7e2021-11-25T17:57:20ZNeuroprotective Effect of Statins in a Rat Model of Chronic Ocular Hypertension10.3390/ijms2222125001422-00671661-6596https://doaj.org/article/c4801c941ff54baea351cff86f4deb7e2021-11-01T00:00:00Zhttps://www.mdpi.com/1422-0067/22/22/12500https://doaj.org/toc/1661-6596https://doaj.org/toc/1422-0067Glaucoma is an optic neuropathy in which the degeneration of retinal ganglion cells (RGCs) results in irreversible vison loss. Therefore, neuroprotection of RGCs from glaucomatous afflictions is crucial for glaucoma treatment. In this study, we aimed to investigate the beneficial effects of statins in the protection of RGCs using a rat model. Glaucomatous injury was induced in rats by chronic ocular hypertension (OHT) achieved after performing a circumlimbal suture. The rats were given either statins such as simvastatin and atorvastatin or a solvent weekly for 6 weeks. Retina sections underwent hematoxylin and eosin, Brn3a, or cleaved casepase-3 staining to evaluate RGC survival. In addition, modulation of glial activation was assessed. While the retinas without statin treatment exhibited increased RGC death due to chronic OHT, statins promoted the survival of RGCs and reduced apoptosis. Statins also suppressed chronic OHT-mediated glial activation in the retina. Our results demonstrate that statins exert neuroprotective effects in rat retinas exposed to chronic OHT, which may support the prospect of statins being a glaucoma treatment.Mi-Lyang KimKyung Rim SungJunki KwonGo Woon ChoiJin A ShinMDPI AGarticleretinal ganglion cellstatinglaucomaneuroprotectionocular hypertensionBiology (General)QH301-705.5ChemistryQD1-999ENInternational Journal of Molecular Sciences, Vol 22, Iss 12500, p 12500 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
retinal ganglion cell statin glaucoma neuroprotection ocular hypertension Biology (General) QH301-705.5 Chemistry QD1-999 |
spellingShingle |
retinal ganglion cell statin glaucoma neuroprotection ocular hypertension Biology (General) QH301-705.5 Chemistry QD1-999 Mi-Lyang Kim Kyung Rim Sung Junki Kwon Go Woon Choi Jin A Shin Neuroprotective Effect of Statins in a Rat Model of Chronic Ocular Hypertension |
description |
Glaucoma is an optic neuropathy in which the degeneration of retinal ganglion cells (RGCs) results in irreversible vison loss. Therefore, neuroprotection of RGCs from glaucomatous afflictions is crucial for glaucoma treatment. In this study, we aimed to investigate the beneficial effects of statins in the protection of RGCs using a rat model. Glaucomatous injury was induced in rats by chronic ocular hypertension (OHT) achieved after performing a circumlimbal suture. The rats were given either statins such as simvastatin and atorvastatin or a solvent weekly for 6 weeks. Retina sections underwent hematoxylin and eosin, Brn3a, or cleaved casepase-3 staining to evaluate RGC survival. In addition, modulation of glial activation was assessed. While the retinas without statin treatment exhibited increased RGC death due to chronic OHT, statins promoted the survival of RGCs and reduced apoptosis. Statins also suppressed chronic OHT-mediated glial activation in the retina. Our results demonstrate that statins exert neuroprotective effects in rat retinas exposed to chronic OHT, which may support the prospect of statins being a glaucoma treatment. |
format |
article |
author |
Mi-Lyang Kim Kyung Rim Sung Junki Kwon Go Woon Choi Jin A Shin |
author_facet |
Mi-Lyang Kim Kyung Rim Sung Junki Kwon Go Woon Choi Jin A Shin |
author_sort |
Mi-Lyang Kim |
title |
Neuroprotective Effect of Statins in a Rat Model of Chronic Ocular Hypertension |
title_short |
Neuroprotective Effect of Statins in a Rat Model of Chronic Ocular Hypertension |
title_full |
Neuroprotective Effect of Statins in a Rat Model of Chronic Ocular Hypertension |
title_fullStr |
Neuroprotective Effect of Statins in a Rat Model of Chronic Ocular Hypertension |
title_full_unstemmed |
Neuroprotective Effect of Statins in a Rat Model of Chronic Ocular Hypertension |
title_sort |
neuroprotective effect of statins in a rat model of chronic ocular hypertension |
publisher |
MDPI AG |
publishDate |
2021 |
url |
https://doaj.org/article/c4801c941ff54baea351cff86f4deb7e |
work_keys_str_mv |
AT milyangkim neuroprotectiveeffectofstatinsinaratmodelofchronicocularhypertension AT kyungrimsung neuroprotectiveeffectofstatinsinaratmodelofchronicocularhypertension AT junkikwon neuroprotectiveeffectofstatinsinaratmodelofchronicocularhypertension AT gowoonchoi neuroprotectiveeffectofstatinsinaratmodelofchronicocularhypertension AT jinashin neuroprotectiveeffectofstatinsinaratmodelofchronicocularhypertension |
_version_ |
1718411827678806016 |